study role intermediate alpha aat deficiency chronic obstructive pulmonary disease copd aat stic measured NUMBER patients copd heterozygosity z variant major cause intermediate aat deficiency primarily mz phenotype accounting NUMBER percent patients compared NUMBER percent control subjects p NUMBER zz homozygosity detected NUMBER percent patients compared NUMBER percent control studies performed present control group NUMBER subjects mean age ms mz patients did differ copd patients zz homozygotes younger NUMBER NUMBER vs NUMBER NUMBER years results resemble previous study NUMBER male veterans pulmonary emphysema suggesting mz phenotype intermediate aat deficiency general probably does predispose development copd prevalence aat deficiency copd patients small approximately NUMBER percent number ms phenotype increased group copd patients NUMBER antitrypsin pi types serum trypsin inhibitory capacity